Arvee Laboratories (India) Limited - Asset Resilience Ratio
Arvee Laboratories (India) Limited (ARVEE) has an Asset Resilience Ratio of 14.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ARVEE strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Arvee Laboratories (India) Limited's Asset Resilience Ratio has changed over time. See Arvee Laboratories (India) Limited balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Arvee Laboratories (India) Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Arvee Laboratories (India) Limited worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs59.60 Million | 14.69% |
| Total Liquid Assets | Rs59.60 Million | 14.69% |
Asset Resilience Insights
- Moderate Liquidity: Arvee Laboratories (India) Limited has 14.69% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Arvee Laboratories (India) Limited Industry Peers by Asset Resilience Ratio
Compare Arvee Laboratories (India) Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Linde plc Ordinary Shares
NASDAQ:LIN |
Specialty Chemicals | 4.26% |
|
Zhongfu Shenying Carbon Fiber Co. Ltd. A
SHG:688295 |
Specialty Chemicals | 2.48% |
|
Ningbo Shanshan Co Ltd
SHG:600884 |
Specialty Chemicals | 0.00% |
|
Incitec Pivot Ltd
AU:IPL |
Specialty Chemicals | 0.03% |
|
Shandong Dongyue Organosilicon Mat
SHE:300821 |
Specialty Chemicals | 0.00% |
|
Huaibei Mining Holdings Co Ltd
SHG:600985 |
Specialty Chemicals | 2.33% |
|
Zhejiang Transfar Co Ltd
SHE:002010 |
Specialty Chemicals | 0.00% |
|
Aarti Industries Limited
NSE:AARTIIND |
Specialty Chemicals | 0.63% |
Annual Asset Resilience Ratio for Arvee Laboratories (India) Limited (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Arvee Laboratories (India) Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 27.41% | Rs104.59 Million ≈ $1.13 Million |
Rs381.58 Million ≈ $4.13 Million |
+12.47pp |
| 2024-03-31 | 14.94% | Rs57.05 Million ≈ $617.02K |
Rs381.99 Million ≈ $4.13 Million |
+12.63pp |
| 2023-03-31 | 2.31% | Rs8.92 Million ≈ $96.44K |
Rs386.85 Million ≈ $4.18 Million |
-14.38pp |
| 2022-03-31 | 16.68% | Rs64.55 Million ≈ $698.03K |
Rs386.85 Million ≈ $4.18 Million |
-4.36pp |
| 2021-03-31 | 21.05% | Rs86.39 Million ≈ $934.30K |
Rs410.46 Million ≈ $4.44 Million |
+8.94pp |
| 2020-03-31 | 12.11% | Rs40.73 Million ≈ $440.44K |
Rs336.25 Million ≈ $3.64 Million |
-2.96pp |
| 2019-03-31 | 15.07% | Rs55.97 Million ≈ $605.34K |
Rs371.49 Million ≈ $4.02 Million |
+10.61pp |
| 2018-03-31 | 4.46% | Rs19.66 Million ≈ $212.56K |
Rs441.17 Million ≈ $4.77 Million |
+1.76pp |
| 2017-03-31 | 2.70% | Rs9.63 Million ≈ $104.17K |
Rs356.75 Million ≈ $3.86 Million |
-- |
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more